{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:23:09Z","timestamp":1793496189250,"version":"4.5.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Nanjing Incubation Program for National Clinical Research Center","award":["2019060001"],"award-info":[{"award-number":["2019060001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12016-021-08864-3","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T14:48:58Z","timestamp":1622645338000},"page":"363-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A Contemporary Review of Behcet\u2019s Syndrome"],"prefix":"10.1007","volume":"61","author":[{"given":"Jingjing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-4775","authenticated-orcid":false,"given":"Xu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"issue":"4","key":"8864_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4081\/reumatismo.2019.1223","volume":"71","author":"DHS Attia","year":"2020","unstructured":"Attia DHS, Abdel Noor RA (2020) Severe Behcet\u2019s disease equally affects both genders in Egyptian patients: a multicentre retrospective follow-up study. Reumatismo 71(4):218\u2013225. https:\/\/doi.org\/10.4081\/reumatismo.2019.1223","journal-title":"Reumatismo"},{"issue":"2","key":"8864_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1573397115666190918153721","volume":"16","author":"E Rajaei","year":"2020","unstructured":"Rajaei E, Jalali MT, Pezeshki SMS, Rezaeeyan H, Maniati M, Elyasi M, Zayeri ZD (2020) Dose HLA-B5, 7, 8, 27, and 51 antigens associated to Behcet\u2019s disease? A study in Southwestern Iran. Curr Rheumatol Rev 16(2):120\u2013124. https:\/\/doi.org\/10.2174\/1573397115666190918153721","journal-title":"Curr Rheumatol Rev"},{"issue":"4","key":"8864_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/14397595.2019.1649103","volume":"30","author":"Y Mizuki","year":"2020","unstructured":"Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N (2020) The influence of HLA-B51 on clinical manifestations among Japanese patients with Behcet\u2019s disease: a nationwide survey. Mod Rheumatol 30(4):708\u2013714. https:\/\/doi.org\/10.1080\/14397595.2019.1649103","journal-title":"Mod Rheumatol"},{"issue":"12","key":"8864_CR4","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1136\/annrheumdis-2015-209059","volume":"75","author":"M Takeuchi","year":"2016","unstructured":"Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Watts NR, Gul A, Kastner DL, Remmers EF (2016) A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet\u2019s disease in HLA-B*51 carriers. Ann Rheum Dis 75(12):2208\u20132211. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209059","journal-title":"Ann Rheum Dis"},{"key":"8864_CR5","doi-asserted-by":"publisher","unstructured":"Islam SMS, Kim HA, Choi B, Jung JY, Lee SM, Suh CH, Sohn S (2019) Differences in expression of human leukocyte antigen class II subtypes and T cell subsets in Behcet\u2019s disease with arthritis. Int J Mol Sci 20 (20). https:\/\/doi.org\/10.3390\/ijms20205044","DOI":"10.3390\/ijms20205044"},{"issue":"1","key":"8864_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/14397595.2019.1705538","volume":"31","author":"H Kato","year":"2021","unstructured":"Kato H, Takeuchi M, Horita N, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Mizuki Y, Hayashi T, Meguro A, Kirino Y, Minegishi K, Nakano H, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Hotta K, Kaneko T, Mizuki N (2021) HLA-A26 is a risk factor for Behcet\u2019s disease ocular lesions. Mod Rheumatol 31(1):214\u2013218. https:\/\/doi.org\/10.1080\/14397595.2019.1705538","journal-title":"Mod Rheumatol"},{"key":"8864_CR7","doi-asserted-by":"publisher","unstructured":"Abdelaleem OO, Fouad NA, Shaker OG, Hussein HA, Ahmed FA, Ali DY, Elsayed HS (2020) Association of miR-146a rs57095329 with Behcet\u2019s disease and its complications. Br J Biomed Sci:1\u20134. https:\/\/doi.org\/10.1080\/09674845.2020.1786284","DOI":"10.1080\/09674845.2020.1786284"},{"issue":"16","key":"8864_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2217\/bmm-2019-0098","volume":"13","author":"G Jadideslam","year":"2019","unstructured":"Jadideslam G, Ansarin K, Sakhinia E, Babaloo Z, Abhari A, Alipour S, Farhadi J, Shirvani SS, Ghojazadeh M, Khabbazi A (2019) Expression levels of miR-21, miR-146b and miR-326 as potential biomarkers in Behcet\u2019s disease. Biomark Med 13(16):1339\u20131348. https:\/\/doi.org\/10.2217\/bmm-2019-0098","journal-title":"Biomark Med"},{"issue":"4","key":"8864_CR9","first-page":"175","volume":"27","author":"MEA Ghembaza","year":"2018","unstructured":"Ghembaza MEA, Lounici A (2018) Relationship between age at onset and clinical characteristics of Behcet\u2019s disease. Acta Dermatovenerol Alp Pannonica Adriat 27(4):175\u2013177","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"11","key":"8864_CR10","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1111\/jdv.15708","volume":"33","author":"YB Lee","year":"2019","unstructured":"Lee YB, Lee JH, Lee SY, Lee JH, Yu DS, Han KD, Park YG (2019) Association between smoking and Behcet\u2019s disease: a nationwide population-based study in Korea. J Eur Acad Dermatol Venereol 33(11):2114\u20132122. https:\/\/doi.org\/10.1111\/jdv.15708","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8864_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa479","author":"P Desai","year":"2020","unstructured":"Desai P, Aldoub K, Jawad AS (2020) Multiple tooth extractions triggering Behcet\u2019s disease. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaa479","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8864_CR12","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1111\/ijd.14992","volume":"59","author":"H Aktas","year":"2020","unstructured":"Aktas H, Ertugrul G (2020) Does obesity prevent occurrence of genital ulcers in women with Behcet\u2019s disease? A striking observation in 17 consecutive patients. Int J Dermatol 59(9):e342\u2013e343. https:\/\/doi.org\/10.1111\/ijd.14992","journal-title":"Int J Dermatol"},{"issue":"2","key":"8864_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.25122\/jml-2019-0153","volume":"13","author":"S Shenavandeh","year":"2020","unstructured":"Shenavandeh S, Asis M, Eftekhari MH, Aflaki E, Abdollahifard GR, Abnavi MA, Ahmadi A (2020) The patients\u2019 beliefs regarding the role of food, mucosal trauma, menstruation, and psychological stress in the recurrence of Behcet\u2019s disease symptoms. J Med Life 13(2):164\u2013169. https:\/\/doi.org\/10.25122\/jml-2019-0153","journal-title":"J Med Life"},{"key":"8864_CR14","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3389\/fimmu.2019.02755","volume":"10","author":"A Castano-Nunez","year":"2019","unstructured":"Castano-Nunez A, Montes-Cano MA, Garcia-Lozano JR, Ortego-Centeno N, Garcia-Hernandez FJ, Espinosa G, Grana-Gil G, Sanchez-Burson J, Julia MR, Solans R, Blanco R, Barnosi-Marin AC, Gomez de la Torre R, Fanlo P, Rodriguez-Carballeira M, Rodriguez-Rodriguez L, Camps T, Castaneda S, Alegre-Sancho JJ, Martin J, Gonzalez-Escribano MF (2019) Association of functional polymorphisms of KIR3DL1\/DS1 with Behcet\u2019s disease. Front Immunol 10:2755. https:\/\/doi.org\/10.3389\/fimmu.2019.02755","journal-title":"Front Immunol"},{"issue":"4","key":"8864_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.5114\/aoms.2020.92911","volume":"16","author":"M Hussain","year":"2020","unstructured":"Hussain M, Chen P, Zhang Y, Tian Y, Du H (2020) Moesin expression is correlated with its involvement in patients with Behcet\u2019s disease. Arch Med Sci 16(4):924\u2013930. https:\/\/doi.org\/10.5114\/aoms.2020.92911","journal-title":"Arch Med Sci"},{"issue":"3","key":"8864_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5114\/aoms.2018.79139","volume":"16","author":"C Yucel","year":"2020","unstructured":"Yucel C, Omma A, Sertoglu E, Sezer S, Turhan T, Ozgurtas T (2020) Evaluation of atherogenic laboratory markers in Behcet\u2019s disease patients with vascular involvement. Arch Med Sci 16(3):531\u2013537. https:\/\/doi.org\/10.5114\/aoms.2018.79139","journal-title":"Arch Med Sci"},{"issue":"5","key":"8864_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/1354750X.2020.1754912","volume":"25","author":"SG Aziz","year":"2020","unstructured":"Aziz SG, Aziz SG, Khabbazi A, Alipour S (2020) The methylation status of TNF-alpha and SOCS3 promoters and the regulation of these gene expressions in patients with Behcet\u2019s disease. Biomarkers 25(5):384\u2013390. https:\/\/doi.org\/10.1080\/1354750X.2020.1754912","journal-title":"Biomarkers"},{"issue":"12","key":"8864_CR18","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1007\/s10792-020-01530-1","volume":"40","author":"AK Cingu","year":"2020","unstructured":"Cingu AK, Turkcu FM, Aktas S, Sahin A, Ayyildiz O (2020) Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet\u2019s disease. Int Ophthalmol 40(12):3441\u20133451. https:\/\/doi.org\/10.1007\/s10792-020-01530-1","journal-title":"Int Ophthalmol"},{"key":"8864_CR19","doi-asserted-by":"publisher","first-page":"154994","DOI":"10.1016\/j.cyto.2020.154994","volume":"127","author":"G Jadideslam","year":"2020","unstructured":"Jadideslam G, Kahroba H, Ansarin K, Sakhinia E, Abhar A, Alipour S, Farhadi J, Seydi Shirvani S, Nouri-Vaskeh M, Mousavi S, Khabbazi A (2020) Interleukin-17 mRNA expression and serum levels in Behcet\u2019s disease. Cytokine 127:154994. https:\/\/doi.org\/10.1016\/j.cyto.2020.154994","journal-title":"Cytokine"},{"key":"8864_CR20","doi-asserted-by":"publisher","unstructured":"Zhong Z, Su G, Kijlstra A, Yang P (2020) Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Prog Retin Eye Res:100866. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100866","DOI":"10.1016\/j.preteyeres.2020.100866"},{"issue":"4","key":"8864_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, Biagi E, Grassi A, Rampelli S, Silvestri E, Centanni M, Cianchi F, Gotti R, Emmi L, Brigidi P, Bizzaro N, De Bellis G, Prisco D, Candela M, D\u2019Elios MM (2015) Behcet\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun Rev 14(4):269\u2013276. https:\/\/doi.org\/10.1016\/j.autrev.2014.11.009","journal-title":"Autoimmun Rev"},{"key":"8864_CR22","doi-asserted-by":"publisher","first-page":"5761392","DOI":"10.1155\/2019\/5761392","volume":"2019","author":"SMS Islam","year":"2019","unstructured":"Islam SMS, Byun HO, Choi B, Sohn S (2019) Inhibition of CD83 alleviates systemic inflammation in herpes simplex virus type 1-induced Behcet\u2019s disease model mouse. Mediators Inflamm 2019:5761392. https:\/\/doi.org\/10.1155\/2019\/5761392","journal-title":"Mediators Inflamm"},{"issue":"3","key":"8864_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/ijmy.ijmy_71_20","volume":"9","author":"R Amri","year":"2020","unstructured":"Amri R, Ayari R, Triki R, Chaabane I, Bouzaidi K, Sbai MA (2020) Humeral artery aneurysm revealing a rare association between tuberculosis and Behcet\u2019s disease. Int J Mycobacteriol 9(3):316\u2013318. https:\/\/doi.org\/10.4103\/ijmy.ijmy_71_20","journal-title":"Int J Mycobacteriol"},{"key":"8864_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fimmu.2020.01192","volume":"11","author":"TB van der Houwen","year":"2020","unstructured":"van der Houwen TB, van Laar JAM, Kappen JH, van Hagen PM, de Zoete MR, van Muijlwijk GH, Berbers RM, Fluit AC, Rogers M, Groot J, Hazelbag CM, Consolandi C, Severgnini M, Peano C, D\u2019Elios MM, Emmi G, Leavis HL (2020) Behcet\u2019s disease under microbiotic surveillance? A combined analysis of two cohorts of Behcet\u2019s disease patients. Front Immunol 11:1192. https:\/\/doi.org\/10.3389\/fimmu.2020.01192","journal-title":"Front Immunol"},{"issue":"6","key":"8864_CR25","doi-asserted-by":"publisher","first-page":"e12663","DOI":"10.1111\/hel.12663","volume":"24","author":"Y Yu","year":"2019","unstructured":"Yu Y, Yao X, Liang J, Lu C, Yan T, Lin J (2019) Is Helicobacter pylori associated with Behcet\u2019s syndrome? A meta-analysis Helicobacter 24(6):e12663. https:\/\/doi.org\/10.1111\/hel.12663","journal-title":"A meta-analysis Helicobacter"},{"issue":"10","key":"8864_CR26","doi-asserted-by":"publisher","first-page":"e033880","DOI":"10.1136\/bmjopen-2019-033880","volume":"10","author":"L Cheng","year":"2020","unstructured":"Cheng L, Li L, Liu C, Yan S, Li Y (2020) Meta-analysis of anti-Saccharomyces cerevisiae antibodies as diagnostic markers of Behcet\u2019s disease with gastrointestinal involvement. BMJ Open 10(10):e033880. https:\/\/doi.org\/10.1136\/bmjopen-2019-033880","journal-title":"BMJ Open"},{"issue":"2","key":"8864_CR27","doi-asserted-by":"publisher","first-page":"001354","DOI":"10.12890\/2020_001354","volume":"7","author":"SM Freitas","year":"2020","unstructured":"Freitas SM, Marques JS, Grilo A, Gomes R, Goncalves FM (2020) Behcet\u2019s disease and tuberculosis: a complex relationship. Eur J Case Rep Intern Med 7(2):001354. https:\/\/doi.org\/10.12890\/2020_001354","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"8864_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/iid3.275","volume":"7","author":"SS Shirvani","year":"2019","unstructured":"Shirvani SS, Nouri M, Sakhinia E, Babaloo Z, Jadideslam G, Shahriar A, Farhadi J, Khabbazi A (2019) The expression and methylation status of vitamin D receptor gene in Behcet\u2019s disease. Immun Inflamm Dis 7(4):308\u2013317. https:\/\/doi.org\/10.1002\/iid3.275","journal-title":"Immun Inflamm Dis"},{"issue":"5\u20136","key":"8864_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1024\/0300-9831\/a000542","volume":"90","author":"A Khabbazi","year":"2020","unstructured":"Khabbazi A, Ghojazadeh M, Hajebrahimi S, Nikniaz Z (2020) Relationship between vitamin D level and Bechcet\u2019s disease activity: a systematic review and meta-analysis. Int J Vitam Nutr Res 90(5\u20136):527\u2013534. https:\/\/doi.org\/10.1024\/0300-9831\/a000542","journal-title":"Int J Vitam Nutr Res"},{"key":"8864_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.05.049","author":"Z Zhong","year":"2020","unstructured":"Zhong Z, Su G, Du L, Zhou Q, Li F, Chi W, Liu S, Zhang M, Zuo X, Yang P (2020) Higher 25-hydroxyvitamin D level is associated with increased risk for Behcet\u2019s disease. Clin Nutr. https:\/\/doi.org\/10.1016\/j.clnu.2020.05.049","journal-title":"Clin Nutr"},{"key":"8864_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12959-020-00225-y","volume":"18","author":"AM Elzanaty","year":"2020","unstructured":"Elzanaty AM, Awad MT, Acharaya A, Sabbagh E, Elsheikh E, AbdAlamir M (2020) Superior vena cava thrombosis and dilated cardiomyopathy as initial presentations of Behcet\u2019s disease. Thromb J 18:12. https:\/\/doi.org\/10.1186\/s12959-020-00225-y","journal-title":"Thromb J"},{"issue":"5","key":"8864_CR32","doi-asserted-by":"publisher","first-page":"e7907","DOI":"10.7759\/cureus.7907","volume":"12","author":"B Ka","year":"2020","unstructured":"Ka B, Tymko C, Subedi R, Virk J, Chaudhuri D (2020) Hughes Stovin syndrome, a rare form of Behcet\u2019s disease presenting as recurrent intracardiac thrombus. Cureus 12(5):e7907. https:\/\/doi.org\/10.7759\/cureus.7907","journal-title":"Cureus"},{"key":"8864_CR33","doi-asserted-by":"publisher","unstructured":"Bettiol A, Prisco D, Emmi G (2020) Behcet: the syndrome. Rheumatology (Oxford) 59 (Suppl 3):iii101-iii107. https:\/\/doi.org\/10.1093\/rheumatology\/kez626","DOI":"10.1093\/rheumatology\/kez626"},{"key":"8864_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.03.058","author":"DA Jabs","year":"2021","unstructured":"Jabs DA, Dick AD, Dunn JP, Kramer M, McCluskey P, Oden N, Okada AA, Palestine AG, Read RW, Thorne JE, Trusko BE, Yeh S, Standardization of Uveitis Nomenclature Working G, (2021) Classification criteria for Behcet disease uveitis. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.058","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"8864_CR35","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1097\/SCS.0000000000003928","volume":"28","author":"R Dogan","year":"2017","unstructured":"Dogan R, Ertas B, Ozucer B, Birday E, Ozturan O, Veyseller B (2017) Olfactory dysfunction associated with neuro-Behcet disease. J Craniofac Surg 28(7):e707\u2013e710. https:\/\/doi.org\/10.1097\/SCS.0000000000003928","journal-title":"J Craniofac Surg"},{"issue":"1","key":"8864_CR36","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1093\/rheumatology\/keaa376","volume":"60","author":"M Komatsumoto","year":"2021","unstructured":"Komatsumoto M, Kono M, Shimizu Y (2021) A case of Behcet\u2019s syndrome initially presenting as recurrent neck pain. Rheumatology (Oxford) 60(1):e12\u2013e13. https:\/\/doi.org\/10.1093\/rheumatology\/keaa376","journal-title":"Rheumatology (Oxford)"},{"key":"8864_CR37","doi-asserted-by":"publisher","unstructured":"Ayar K, Okmen BM, Altan L, Ozturk EK (2020) Central sensitization and its relationship with health profile in Behcet's disease. Mod Rheumatol:1\u20137. https:\/\/doi.org\/10.1080\/14397595.2020.1780076","DOI":"10.1080\/14397595.2020.1780076"},{"issue":"1","key":"8864_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.31138\/mjr.31.1.78","volume":"31","author":"S Partalidou","year":"2020","unstructured":"Partalidou S, Tsiakalou V, Vassilakos I, Kassimos D (2020) Walking instability in a patient with known neuro-Behcet\u2019s disease. Mediterr J Rheumatol 31(1):78\u201380. https:\/\/doi.org\/10.31138\/mjr.31.1.78","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"8864_CR39","first-page":"124","volume":"32","author":"U Naveed","year":"2020","unstructured":"Naveed U, Iqbal A, Qurrat-Ul A, Hamdani MA, Butt MA, Ashraf MA (2020) Behcet\u2019s disease presenting with life threatening manifestation of cerebral venous thrombosis. J Ayub Med Coll Abbottabad 32(1):124\u2013126","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"8","key":"8864_CR40","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1308\/rcsann.2019.0134","volume":"101","author":"AE Mousa","year":"2019","unstructured":"Mousa AE, Okasha M, Isaacs JD, Price DA, Bhatnagar P, Joshi A, Surash S (2019) Brain pseudotumour secondary to Behcet\u2019s disease. Ann R Coll Surg Engl 101(8):e164\u2013e168. https:\/\/doi.org\/10.1308\/rcsann.2019.0134","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"8864_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13023-021-01772-x","volume":"16","author":"CC Hou","year":"2021","unstructured":"Hou CC, Ye JF, Ma HF, Guan JL (2021) Clinical characteristics and risk factors of intestinal involvement in Behcet\u2019s syndrome patients: a cross-sectional study from a single center. Orphanet J Rare Dis 16(1):132. https:\/\/doi.org\/10.1186\/s13023-021-01772-x","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"8864_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5213\/inj.2040004.002","volume":"24","author":"A Baser","year":"2020","unstructured":"Baser A, Zumrutbas AE, Ozlulerden Y, Alkis O, Oztekin A, Celen S, Aybek Z (2020) Is there a correlation between Behcet disease and lower urinary tract symptoms? Int Neurourol J 24(2):150\u2013155. https:\/\/doi.org\/10.5213\/inj.2040004.002","journal-title":"Int Neurourol J"},{"issue":"7","key":"8864_CR43","first-page":"458","volume":"22","author":"W Naser","year":"2020","unstructured":"Naser W, Lishner M (2020) Behcet disease presenting as acute myocardial infarction. Isr Med Assoc J 22(7):458\u2013460","journal-title":"Isr Med Assoc J"},{"key":"8864_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.11604\/pamj.2020.36.3.22373","volume":"36","author":"SB Farhat","year":"2020","unstructured":"Farhat SB, Slim M (2020) A coronary artery aneurysm revealing a Behcet\u2019s disease: a case report. Pan Afr Med J 36:3. https:\/\/doi.org\/10.11604\/pamj.2020.36.3.22373","journal-title":"Pan Afr Med J"},{"issue":"7","key":"8864_CR45","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/echo.14771","volume":"37","author":"MG Ramoglu","year":"2020","unstructured":"Ramoglu MG, Atalay S, Ucar T, Fitoz S, Ozcakar ZB, Ciftci E, Tutar E (2020) Multiple intra-cardiac masses: A life-threatening complication of Behcet\u2019s disease. Echocardiography 37(7):1077\u20131079. https:\/\/doi.org\/10.1111\/echo.14771","journal-title":"Echocardiography"},{"key":"8864_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.11604\/pamj.2020.36.92.23741","volume":"36","author":"Y Amchich","year":"2020","unstructured":"Amchich Y, Reguig N, Boucaid A, Belghoule R, Zegmout A, Bourkadi JE (2020) Intracardiac thrombus in Behcet\u2019s disease: a rare case in Morocco. Pan Afr Med J 36:92. https:\/\/doi.org\/10.11604\/pamj.2020.36.92.23741","journal-title":"Pan Afr Med J"},{"issue":"3","key":"8864_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3988\/jcn.2020.16.3.499","volume":"16","author":"E Park","year":"2020","unstructured":"Park E, Lee SU, Kim HJ, Choi JY, Im GJ, Yu S, Kim JS (2020) Neuro-Behcet\u2019s disease presenting as isolated vestibular syndrome. J Clin Neurol 16(3):499\u2013501. https:\/\/doi.org\/10.3988\/jcn.2020.16.3.499","journal-title":"J Clin Neurol"},{"issue":"9","key":"8864_CR48","doi-asserted-by":"publisher","first-page":"e10273","DOI":"10.7759\/cureus.10273","volume":"12","author":"HF Alkhurassi","year":"2020","unstructured":"Alkhurassi HF, Ocheltree MR, Alsomali A, Alqunfoidi RA, Saadallah A Sr (2020) Pleural effusion presenting in a young man with Behcet\u2019s disease. Cureus 12(9):e10273. https:\/\/doi.org\/10.7759\/cureus.10273","journal-title":"Cureus"},{"issue":"21","key":"8864_CR49","doi-asserted-by":"publisher","first-page":"e20221","DOI":"10.1097\/MD.0000000000020221","volume":"99","author":"P Zhou","year":"2020","unstructured":"Zhou P, Wu Q, Li J (2020) Vocal cord involvement and hoarseness in a patient with Behcets disease: a rare case report. Medicine (Baltimore) 99(21):e20221. https:\/\/doi.org\/10.1097\/MD.0000000000020221","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"8864_CR50","doi-asserted-by":"publisher","first-page":"e0138","DOI":"10.1097\/MD.0000000000010138","volume":"97","author":"FH Ju","year":"2018","unstructured":"Ju FH, Xu TZ, Hong HH, Mao H, Wang M, Wang Z (2018) Behcet disease combined with Sjogren syndrome: a unique case report and literature review. Medicine (Baltimore) 97(12):e0138. https:\/\/doi.org\/10.1097\/MD.0000000000010138","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"8864_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinre.2019.12.003","volume":"44","author":"AC Desbois","year":"2020","unstructured":"Desbois AC, Plessier A (2020) Why and when to diagnose Behcet\u2019s disease in patients with Budd Chiari Syndrome? Clin Res Hepatol Gastroenterol 44(4):385\u2013386. https:\/\/doi.org\/10.1016\/j.clinre.2019.12.003","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"8864_CR52","doi-asserted-by":"publisher","first-page":"e00352","DOI":"10.14309\/crj.0000000000000352","volume":"7","author":"SK Vuyyuru","year":"2020","unstructured":"Vuyyuru SK, Gamanagatti S, Shalimar, (2020) Behcet\u2019s disease with Budd-Chiari syndrome and challenges in its management. ACG Case Rep J 7(3):e00352. https:\/\/doi.org\/10.14309\/crj.0000000000000352","journal-title":"ACG Case Rep J"},{"issue":"4","key":"8864_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.31138\/mjr.30.4.228","volume":"30","author":"MB Alanazi","year":"2019","unstructured":"Alanazi MB, Asiri YO, Al-Homood IA (2019) IgG4-related disease coexisting with Behcet\u2019s disease. Mediterr J Rheumatol 30(4):228\u2013230. https:\/\/doi.org\/10.31138\/mjr.30.4.228","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"8864_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.31138\/mjr.31.1.92","volume":"31","author":"S Suarez-Diaz","year":"2020","unstructured":"Suarez-Diaz S, Caminal-Montero L (2020) Overlapping between IgG4-RD and Behcet\u2019s disease. Mediterr J Rheumatol 31(1):92. https:\/\/doi.org\/10.31138\/mjr.31.1.92","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"8864_CR55","doi-asserted-by":"publisher","first-page":"e7647","DOI":"10.7759\/cureus.7647","volume":"12","author":"M Al-Sardi","year":"2020","unstructured":"Al-Sardi M, Abdulhadi D, Al-Jishi F, Deraan K (2020) Castleman\u2019s disease with pulmonary artery aneurysm: a rare presentation of Behcet\u2019s disease. Cureus 12(4):e7647. https:\/\/doi.org\/10.7759\/cureus.7647","journal-title":"Cureus"},{"issue":"4","key":"8864_CR56","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11845-020-02244-0","volume":"189","author":"DC Guven","year":"2020","unstructured":"Guven DC, Bolek EC, Altintop SE, Celikten B, Aktas BY, Kiraz S, Gullu I, Karadag O, Dizdar O (2020) Cancer incidence in Behcet\u2019s disease. Ir J Med Sci 189(4):1209\u20131214. https:\/\/doi.org\/10.1007\/s11845-020-02244-0","journal-title":"Ir J Med Sci"},{"issue":"44","key":"8864_CR57","doi-asserted-by":"publisher","first-page":"e17735","DOI":"10.1097\/MD.0000000000017735","volume":"98","author":"X Wang","year":"2019","unstructured":"Wang X, Peng Y, Gao J, Han S, Li Y (2019) Risk of malignancy in Behcet disease: a meta-analysis with systematic review. Medicine (Baltimore) 98(44):e17735. https:\/\/doi.org\/10.1097\/MD.0000000000017735","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"8864_CR58","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10787-019-00567-8","volume":"27","author":"F Djaballah-Ider","year":"2019","unstructured":"Djaballah-Ider F, Djaballah A, Djeraba Z, Chaib S, Touil-Boukoffa C (2019) Auto-immunity profile evaluation during different clinical manifestations of Behcet disease in Algerian patients: effect of corticosteroid treatment. Inflammopharmacology 27(6):1113\u20131122. https:\/\/doi.org\/10.1007\/s10787-019-00567-8","journal-title":"Inflammopharmacology"},{"issue":"6 Suppl 115","key":"8864_CR59","first-page":"28","volume":"36","author":"LL Prado","year":"2018","unstructured":"Prado LL, Goncalves CR, Viana VT, Saad CGS, Bonfa E (2018) Anti-alpha-enolase antibodies in Behcet\u2019s disease: a marker of mucocutaneous and articular disease activity? Clin Exp Rheumatol 36(6 Suppl 115):28\u201332","journal-title":"Clin Exp Rheumatol"},{"key":"8864_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2147\/OARRR.S225168","volume":"11","author":"A Floris","year":"2019","unstructured":"Floris A, Piga M, Pinna S, Angioni MM, Congia M, Mascia P, Chessa E, Cangemi I, Mathieu A, Cauli A (2019) Assessment Of circulating endothelial cells and their progenitors as potential biomarkers of disease activity and damage accrual in Behcet\u2019s syndrome. Open Access Rheumatol 11:219\u2013227. https:\/\/doi.org\/10.2147\/OARRR.S225168","journal-title":"Open Access Rheumatol"},{"issue":"1","key":"8864_CR61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13075-018-1712-y","volume":"20","author":"W Zheng","year":"2018","unstructured":"Zheng W, Wu X, Goudarzi M, Shi J, Song W, Li C, Liu J, Chen H, Zhang X, Zeng X, Li HH (2018) Metabolomic alterations associated with Behcet\u2019s disease. Arthritis Res Ther 20(1):214. https:\/\/doi.org\/10.1186\/s13075-018-1712-y","journal-title":"Arthritis Res Ther"},{"key":"8864_CR62","doi-asserted-by":"publisher","first-page":"2405150","DOI":"10.1155\/2018\/2405150","volume":"2018","author":"A Puccetti","year":"2018","unstructured":"Puccetti A, Pelosi A, Fiore PF, Patuzzo G, Lunardi C, Dolcino M (2018) MicroRNA expression profiling in Behcet\u2019s disease. J Immunol Res 2018:2405150. https:\/\/doi.org\/10.1155\/2018\/2405150","journal-title":"J Immunol Res"},{"key":"8864_CR63","doi-asserted-by":"publisher","unstructured":"Wang L-W, Luo L-L, Zhang W, Zeng X-S, Cui P-G (2020) Behcet\u2019s disease with generalized polymorphous cutaneous lesions. International Journal of Dermatology and Venereology Publish Ahead of Print. https:\/\/doi.org\/10.1097\/jd9.0000000000000064","DOI":"10.1097\/jd9.0000000000000064"},{"key":"8864_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00592-w","author":"DM Perez-Garza","year":"2021","unstructured":"Perez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M (2021) Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. https:\/\/doi.org\/10.1007\/s40257-021-00592-w","journal-title":"Am J Clin Dermatol"},{"key":"8864_CR65","unstructured":"Rahman S, Daveluy S (2020) Pathergy Test. In: StatPearls. Treasure Island (FL),"},{"key":"8864_CR66","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease (1990). Lancet 335 (8697):1078\u20131080","DOI":"10.1016\/0140-6736(90)92643-V"},{"issue":"3","key":"8864_CR67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet's D","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s D (2014) The International Criteria for Behcet\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338\u2013347. https:\/\/doi.org\/10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8864_CR68","unstructured":"Mumcu G, Karacayli U, Yay M, Aksoy A, Tas MN, Armagan B, Sari A, Bozca BC, Tekgoz E, Karadag DT, Badak SO, Tecer D, Bes C, Sahin A, Erken E, Cefle A, Cinar M, Yilmaz S, Alpsoy E, Senel S, Bilge SY, Kasifoglu T, Karadag O, Aksu K, Keser G, Alibaz-Oner F, Inanc N, Ergun T, Direskeneli H (2019) Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study. Clin Exp Rheumatol 37 Suppl 121 (6):98\u2013104"},{"key":"8864_CR69","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/CCID.S265169","volume":"13","author":"P Limtong","year":"2020","unstructured":"Limtong P, Chanprapaph K, Vachiramon V, Ngamjanyaporn P (2020) Cutaneous and extracutaneous manifestations of Behcet\u2019s disease linked to its disease activity and prognosis. Clin Cosmet Investig Dermatol 13:639\u2013647. https:\/\/doi.org\/10.2147\/CCID.S265169","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"8864_CR70","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 38(8):728\u2013733. https:\/\/doi.org\/10.1093\/rheumatology\/38.8.728","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8864_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, Lyons JJ, Yu X, Ouyang C, Chen C, Chin DT, Zaal K, Chandrasekharappa SC, Hanson EP, Yu Z, Mullikin JC, Hasni SA, Wertz IE, Ombrello AK, Stone DL, Hoffmann P, Jones A, Barham BK, Leavis HL, van Royen-Kerkof A, Sibley C, Batu ED, Gul A, Siegel RM, Boehm M, Milner JD, Ozen S, Gadina M, Chae J, Laxer RM, Kastner DL, Aksentijevich I (2016) Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 48(1):67\u201373. https:\/\/doi.org\/10.1038\/ng.3459","journal-title":"Nat Genet"},{"issue":"2","key":"8864_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.22034\/iji.2020.85507.1717","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang D, Zhang S, Ding P, Zhao Y, Zhang X, Zhao Q (2020) Immune-related adverse events mimicking Behcet\u2019s disease in a gastric cancer patient following camrelizumab treatment. Iran J Immunol 17(2):167\u2013171. https:\/\/doi.org\/10.22034\/iji.2020.85507.1717","journal-title":"Iran J Immunol"},{"issue":"4","key":"8864_CR73","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/1078155219877219","volume":"26","author":"S Thomas","year":"2020","unstructured":"Thomas S, Bae C, Joy-Ann T, Traverse W (2020) Behcet\u2019s-like syndrome following pembrolizumab: an immune-related adverse event associated with programmed death receptor-1 inhibitor therapy. J Oncol Pharm Pract 26(4):995\u2013999. https:\/\/doi.org\/10.1177\/1078155219877219","journal-title":"J Oncol Pharm Pract"},{"key":"8864_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14196","author":"A Calleja Algarra","year":"2020","unstructured":"Calleja Algarra A, Aragon Miguel R, Andres Lencina JJ, Pinilla Martin B, Vico Alonso C, Rodriguez Peralto JL, Ortiz Romero PL, Rivera Diaz R (2020) Behcet\u2019s-like disease during secukinumab treatment: new paradoxical reaction? J Dtsch Dermatol Ges. https:\/\/doi.org\/10.1111\/ddg.14196","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"8864_CR75","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kotter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H (2018) 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann Rheum Dis 77(6):808\u2013818. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8864_CR76","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bjoms.2020.07.027","volume":"58","author":"A Senusi","year":"2020","unstructured":"Senusi A, Kang A, Buchanan JAG, Adesanya A, Aloraini G, Stanford M, Fortune F (2020) New mouthwash: an efficacious intervention for oral ulceration associated with Behcet\u2019s disease. Br J Oral Maxillofac Surg 58(8):1034\u20131039. https:\/\/doi.org\/10.1016\/j.bjoms.2020.07.027","journal-title":"Br J Oral Maxillofac Surg"},{"key":"8864_CR77","unstructured":"Benson RM, Kirwan J, Moots RJ (2019) A novel treatment in the management of genital ulceration in Behcet's disease. Clin Exp Rheumatol 37 Suppl 121 (6):158"},{"issue":"1","key":"8864_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.15171\/jlms.2020.18","volume":"11","author":"N Zand","year":"2020","unstructured":"Zand N, Mansouri P, Rezaee Khiabanloo S, Fateh M, Ataie-Fashtami L, Safaee Naraghi Z, Shirkavand A (2020) The immediate pain-relieving effects of non-thermal CO2 laser therapy on genital ulcers of Behcet\u2019s disease: a case report. J Lasers Med Sci 11(1):108\u2013111. https:\/\/doi.org\/10.15171\/jlms.2020.18","journal-title":"J Lasers Med Sci"},{"key":"8864_CR79","doi-asserted-by":"publisher","unstructured":"Mumcu G, Alibaz Oner F, Ergun T, Direskeneli RH (2020) Decreasing incidence and severity of Behcet's disease: a changing trend in epidemiological spectrum possibly associated with oral health. Turk J Med Sci 50 (SI-2):1587\u20131590. https:\/\/doi.org\/10.3906\/sag-2003-147","DOI":"10.3906\/sag-2003-147"},{"key":"8864_CR80","unstructured":"Verboom DM, van der Houwen TB, Kappen JH, van Daele PLA, Dik WA, Schreurs MWJ, van Hagen PM, van Laar JAM (2019) Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Behcet's disease without formation of antidrug antibodies. Clin Exp Rheumatol 37 Suppl 121 (6):43\u201347"},{"issue":"8","key":"8864_CR81","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jop.13020","volume":"49","author":"M Cabras","year":"2020","unstructured":"Cabras M, Carrozzo M, Gambino A, Broccoletti R, Sciascia S, Baldovino S, Arduino PG (2020) Value of colchicine as treatment for recurrent oral ulcers: a systematic review. J Oral Pathol Med 49(8):731\u2013740. https:\/\/doi.org\/10.1111\/jop.13020","journal-title":"J Oral Pathol Med"},{"issue":"10","key":"8864_CR82","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/art.40912","volume":"71","author":"A Mirouse","year":"2019","unstructured":"Mirouse A, Barete S, Desbois AC, Comarmond C, Sene D, Domont F, Bodaghi B, Ferfar Y, Cacoub P, Saadoun D, French Behcet\u2019s N (2019) Long-term outcome of ustekinumab therapy for Behcet\u2019s disease. Arthritis Rheumatol 71(10):1727\u20131732. https:\/\/doi.org\/10.1002\/art.40912","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"8864_CR83","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/annrheumdis-2020-217108","volume":"79","author":"F Fagni","year":"2020","unstructured":"Fagni F, Bettiol A, Talarico R, Lopalco G, Silvestri E, Urban ML, Russo PAJ, Di Scala G, Emmi G, Prisco D (2020) Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behcet\u2019s phenotype: a multicentre study. Ann Rheum Dis 79(8):1098\u20131104. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217108","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8864_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/rheumatology\/kez267","volume":"59","author":"G De Luca","year":"2020","unstructured":"De Luca G, Cariddi A, Campochiaro C, Vanni D, Boffini N, Tomelleri A, Cavalli G, Dagna L (2020) Efficacy and safety of apremilast for Behcet\u2019s syndrome: a real-life single-centre Italian experience. Rheumatology (Oxford) 59(1):171\u2013175. https:\/\/doi.org\/10.1093\/rheumatology\/kez267","journal-title":"Rheumatology (Oxford)"},{"issue":"20","key":"8864_CR85","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","volume":"381","author":"G Hatemi","year":"2019","unstructured":"Hatemi G, Mahr A, Ishigatsubo Y, Song YW, Takeno M, Kim D, Melikoglu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y (2019) Trial of apremilast for oral ulcers in Behcet\u2019s syndrome. N Engl J Med 381(20):1918\u20131928. https:\/\/doi.org\/10.1056\/NEJMoa1816594","journal-title":"N Engl J Med"},{"issue":"4","key":"8864_CR86","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/08923973.2020.1789656","volume":"42","author":"AD Yalcin","year":"2020","unstructured":"Yalcin AD, Yalcin AN (2020) A case of asthma with Behcet\u2019s disease: successful treatment with omalizumab and its effects on recurrent aphthous lesions. Immunopharmacol Immunotoxicol 42(4):379\u2013382. https:\/\/doi.org\/10.1080\/08923973.2020.1789656","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"8864_CR87","doi-asserted-by":"publisher","unstructured":"Maciel ML, Novello M, Neves FS (2017) Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behcet\u2019s disease. Rheumatol Adv Pract 1 (1):rkx004. https:\/\/doi.org\/10.1093\/rap\/rkx004","DOI":"10.1093\/rap\/rkx004"},{"issue":"1","key":"8864_CR88","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13063-020-04444-6","volume":"21","author":"G Pagliai","year":"2020","unstructured":"Pagliai G, Dinu M, Fiorillo C, Becatti M, Turroni S, Emmi G, Sofi F (2020) Modulation of gut microbiota through nutritional interventions in Behcet\u2019s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial. Trials 21(1):511. https:\/\/doi.org\/10.1186\/s13063-020-04444-6","journal-title":"Trials"},{"issue":"11","key":"8864_CR89","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/jgh.14690","volume":"34","author":"H Kinoshita","year":"2019","unstructured":"Kinoshita H, Nishioka H, Ikeda A, Ikoma K, Sameshima Y, Ohi H, Tatsuno M, Kouyama J, Kawamoto C, Mitsui T, Tamura Y, Hashimoto Y, Nishio M, Ogashiwa T, Saigusa Y, Maeda S, Kimura H, Kunisaki R, Koike K (2019) Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Behcet\u2019s disease. J Gastroenterol Hepatol 34(11):1929\u20131939. https:\/\/doi.org\/10.1111\/jgh.14690","journal-title":"J Gastroenterol Hepatol"},{"key":"8864_CR90","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2020.00013","author":"Y Suzuki","year":"2020","unstructured":"Suzuki Y, Hagiwara T, Kobayashi M, Morita K, Shimamoto T, Hibi T (2020) Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behcet\u2019s disease: results from a large real-world observational study. Intest Res. https:\/\/doi.org\/10.5217\/ir.2020.00013","journal-title":"Intest Res"},{"issue":"7","key":"8864_CR91","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s00393-020-00816-0","volume":"79","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Kim KT, Lee SG, Kim Y (2020) Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behcet\u2019s disease. Z Rheumatol 79(7):702\u2013706. https:\/\/doi.org\/10.1007\/s00393-020-00816-0","journal-title":"Z Rheumatol"},{"issue":"2","key":"8864_CR92","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/09273948.2018.1511810","volume":"28","author":"C Fabiani","year":"2020","unstructured":"Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L (2020) The presence of uveitis is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Behcet\u2019s disease. Ocul Immunol Inflamm 28(2):298\u2013304. https:\/\/doi.org\/10.1080\/09273948.2018.1511810","journal-title":"Ocul Immunol Inflamm"},{"issue":"46","key":"8864_CR93","doi-asserted-by":"publisher","first-page":"e17979","DOI":"10.1097\/MD.0000000000017979","volume":"98","author":"T Asano","year":"2019","unstructured":"Asano T, Sato S, Furuya MY, Takahashi H, Shichishima-Nakamura A, Ohkawara H, Fujiwara T, Gunji N, Hashimoto C, Momma T, Saito M, Nakano H, Watanabe G, Temmoku J, Fujita Y, Matsuoka N, Kobayashi H, Watanabe H, Mouri M, Mashiyama F, Sakuma H, Ohira H, Mori M, Ikezoe T, Migita K (2019) Intestinal Behcet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: a case report. Medicine (Baltimore) 98(46):e17979. https:\/\/doi.org\/10.1097\/MD.0000000000017979","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"8864_CR94","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00535-020-01690-y","volume":"55","author":"K Watanabe","year":"2020","unstructured":"Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, Arai K, Uchino M, Koganei K, Kobayashi T, Takeno M, Ueno F, Matsumoto T, Mizuki N, Suzuki Y, Hisamatsu T (2020) Evidence-based diagnosis and clinical practice guidelines for intestinal Behcet\u2019s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol 55(7):679\u2013700. https:\/\/doi.org\/10.1007\/s00535-020-01690-y","journal-title":"J Gastroenterol"},{"issue":"3","key":"8864_CR95","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/09273948.2019.1587473","volume":"28","author":"H Eser-Ozturk","year":"2020","unstructured":"Eser-Ozturk H, Sullu Y (2020) The results of interferon-alpha treatment in Behcet uveitis. Ocul Immunol Inflamm 28(3):498\u2013504. https:\/\/doi.org\/10.1080\/09273948.2019.1587473","journal-title":"Ocul Immunol Inflamm"},{"key":"8864_CR96","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316892","author":"H Keino","year":"2020","unstructured":"Keino H, Watanabe T, Nakayama M, Komagata Y, Fukuoka K, Okada AA (2020) Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behcet\u2019s disease. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-316892","journal-title":"Br J Ophthalmol"},{"key":"8864_CR97","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.jaut.2020.102481","volume":"113","author":"M Leclercq","year":"2020","unstructured":"Leclercq M, Langlois V, Girszyn N, Le Besnerais M, Benhamou Y, Levesque H, Muraine M, Gueudry J (2020) Comparison of conventional immunosuppressive drugs versus anti-TNF-alpha agents in non-infectious non-anterior uveitis. J Autoimmun 113:102481. https:\/\/doi.org\/10.1016\/j.jaut.2020.102481","journal-title":"J Autoimmun"},{"issue":"12","key":"8864_CR98","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/art.41026","volume":"71","author":"B Atienza-Mateo","year":"2019","unstructured":"Atienza-Mateo B, Martin-Varillas JL, Calvo-Rio V, Demetrio-Pablo R, Beltran E, Sanchez-Burson J, Mesquida M, Adan A, Hernandez MV, Hernandez-Garfella M, Valls-Pascual E, Martinez-Costa L, Sellas-Fernandez A, Cordero-Coma M, Diaz-Llopis M, Gallego R, Garcia-Serrano JL, Ortego-Centeno N, Herreras JM, Fonollosa A, Garcia-Aparicio AM, Maiz-Alonso O, Blanco A, Torre-Salaberri I, Fernandez-Espartero C, Jovani V, Peiteado D, Pato E, Cruz J, Fernandez-Cid C, Aurrecoechea E, Garcia-Arias M, Castaneda S, Caracuel-Ruiz MA, Montilla-Morales CA, Atanes-Sandoval A, Francisco F, Insua S, Gonzalez-Suarez S, Sanchez-Andrade A, Gamero F, Linares Ferrando LF, Romero-Bueno F, Garcia-Gonzalez AJ, Gonzalez RA, Muro EM, Carrasco-Cubero C, Olive A, Prior A, Vazquez J, Ruiz-Moreno O, Jimenez-Zorzo F, Manero J, Munoz Fernandez S, Fernandez-Carballido C, Rubio-Romero E, Pages FA, Toyos-Saenz de Miera FJ, Martinez MG, Diaz-Valle D, Lopez Longo FJ, Nolla JM, Alvarez ER, Martinez MR, Gonzalez-Lopez JJ, Rodriguez-Cundin P, Hernandez JL, Gonzalez-Gay MA, Blanco R (2019) Comparative study of infliximab versus adalimumab in refractory uveitis due to Behcet\u2019s disease: national multicenter study of 177 cases. Arthritis Rheumatol 71(12):2081\u20132089. https:\/\/doi.org\/10.1002\/art.41026","journal-title":"Arthritis Rheumatol"},{"key":"8864_CR99","doi-asserted-by":"publisher","unstructured":"Kunimi K, Usui Y, Asakage M, Maehara C, Tsubota K, Mitsuhashi R, Umazume A, Kezuka T, Sakai JI, Goto H (2020) Anti-TNF-alpha Therapy for Refractory Uveitis Associated with Behcet's Syndrome and Sarcoidosis: A Single Center Study of 131 Patients. Ocul Immunol Inflamm:1\u20138. https:\/\/doi.org\/10.1080\/09273948.2020.1791346","DOI":"10.1080\/09273948.2020.1791346"},{"issue":"2","key":"8864_CR100","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/09273948.2019.1606256","volume":"28","author":"N Yalcindag","year":"2020","unstructured":"Yalcindag N, Kose HC (2020) Comparison of the treatment results for Behcet uveitis in patients treated with infliximab and interferon. Ocul Immunol Inflamm 28(2):305\u2013314. https:\/\/doi.org\/10.1080\/09273948.2019.1606256","journal-title":"Ocul Immunol Inflamm"},{"key":"8864_CR101","doi-asserted-by":"publisher","unstructured":"De Simone L, Invernizzi A, Aldigeri R, Mastrofilippo V, Marvisi C, Gozzi F, Bolletta E, Adani C, Pipitone N, Muratore F, Fontana L, Salvarani C, Cimino L (2020) Effectiveness of infliximab and interferon alpha-2a for the treatment of Behcet\u2019s uveitis: customizing therapy according to the clinical features. Ocul Immunol Inflamm:1\u20139. https:\/\/doi.org\/10.1080\/09273948.2020.1815797","DOI":"10.1080\/09273948.2020.1815797"},{"issue":"11","key":"8864_CR102","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/annrheumdis-2020-217307","volume":"79","author":"J Liu","year":"2020","unstructured":"Liu J, Hou Y, Sun L, Li C, Li L, Zhao Y, Zeng X, Zhang F, Zheng W (2020) A pilot study of tofacitinib for refractory Behcet\u2019s syndrome. Ann Rheum Dis 79(11):1517\u20131520. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217307","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8864_CR103","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/rheumatology\/kez598","volume":"59","author":"M Gurcan","year":"2020","unstructured":"Gurcan M, Esatoglu SN, Hamuryudan V, Saygin D, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Yurdakul S, Yazici H, Hatemi G (2020) Long term follow-up of Behcet\u2019s syndrome patients treated with cyclophosphamide. Rheumatology (Oxford) 59(9):2264\u20132271. https:\/\/doi.org\/10.1093\/rheumatology\/kez598","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8864_CR104","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1708538120927701","volume":"28","author":"DY Kehribar","year":"2020","unstructured":"Kehribar DY, Ozgen M (2020) Infliximab treatment in refractory vascular Behcet\u2019s disease: a single-center experience. Vascular 28(6):829\u2013833. https:\/\/doi.org\/10.1177\/1708538120927701","journal-title":"Vascular"},{"issue":"1","key":"8864_CR105","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/rheumatology\/keaa365","volume":"60","author":"H Satis","year":"2021","unstructured":"Satis H, Cindil E, Atas N, Salman RB, Tufan A (2021) Successful treatment of coronary artery aneurysm with infliximab in a Behcet\u2019s disease patient. Rheumatology (Oxford) 60(1):e10\u2013e11. https:\/\/doi.org\/10.1093\/rheumatology\/keaa365","journal-title":"Rheumatology (Oxford)"},{"key":"8864_CR106","unstructured":"Utsunomiya A, Watanabe T, Shizuki K, Jodo S (2019) Successful treatment with adalimumab for autoimmune sensorineural hearing loss in a patient with Behcet's disease. Clin Exp Rheumatol 37 Suppl 121 (6):164\u2013165"},{"key":"8864_CR107","doi-asserted-by":"publisher","first-page":"577308","DOI":"10.1016\/j.jneuroim.2020.577308","volume":"346","author":"C Garcia-Estrada","year":"2020","unstructured":"Garcia-Estrada C, Casallas-Vanegas A, Zabala-Angeles I, Gomez-Figueroa E, Rivas-Alonso V, Flores-Rivera J (2020) Rituximab as an effective therapeutic option in refractory Neuro-Behcet syndrome. J Neuroimmunol 346:577308. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577308","journal-title":"J Neuroimmunol"},{"key":"8864_CR108","doi-asserted-by":"publisher","unstructured":"Liu J, Yan D, Wang Z, Yang Y, Zhang S, Wu D, Peng L, Liu Z, Zheng W (2020) Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behcet's syndrome: case series and literature review. Ther Adv Musculoskelet Dis 12:1759720X20971908. https:\/\/doi.org\/10.1177\/1759720X20971908","DOI":"10.1177\/1759720X20971908"},{"issue":"4","key":"8864_CR109","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3899\/jrheum.130847","volume":"41","author":"V Hamuryudan","year":"2014","unstructured":"Hamuryudan V, Hatemi G, Tascilar K, Yurdakul S, Mat C, Ozyazgan Y, Seyahi E, Ugurlu S, Yazici H (2014) Colchicine in Behcet syndrome: a longterm survey of patients in a controlled trial. J Rheumatol 41(4):735\u2013738. https:\/\/doi.org\/10.3899\/jrheum.130847","journal-title":"J Rheumatol"},{"issue":"5","key":"8864_CR110","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE et al (1990) A controlled trial of azathioprine in Behcet\u2019s syndrome. N Engl J Med 322(5):281\u2013285. https:\/\/doi.org\/10.1056\/NEJM199002013220501","journal-title":"N Engl J Med"},{"key":"8864_CR111","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behcet N (2015) Efficacy of anti-TNF alpha in severe and\/or refractory Behcet\u2019s disease: multicenter study of 124 patients. J Autoimmun 62:67\u201374. https:\/\/doi.org\/10.1016\/j.jaut.2015.06.005","journal-title":"J Autoimmun"},{"issue":"1","key":"8864_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reuma.2019.03.002","volume":"17","author":"A Khabbazi","year":"2021","unstructured":"Khabbazi A, Ebrahimzadeh Attari V, Asghari Jafarabadi M, Malek Mahdavi A (2021) Quality of life in patients with Behcet disease and its relation with clinical symptoms and disease activity. Reumatol Clin 17(1):1\u20136. https:\/\/doi.org\/10.1016\/j.reuma.2019.03.002","journal-title":"Reumatol Clin"},{"issue":"10","key":"8864_CR113","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/rheumatology\/keaa010","volume":"59","author":"T Thomas","year":"2020","unstructured":"Thomas T, Chandan JS, Subramanian A, Gokhale K, Gkoutos G, Harper L, Buckley C, Chandratre P, Raza K, Situnayake D, Nirantharakumar K (2020) Epidemiology, morbidity and mortality in Behcet\u2019s disease: a cohort study using The Health Improvement Network (THIN). Rheumatology (Oxford) 59(10):2785\u20132795. https:\/\/doi.org\/10.1093\/rheumatology\/keaa010","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:22:49Z","timestamp":1659079369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8864"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08864-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"17 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}